Tekla Capital Management as of Sept. 30, 2012
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 68 positions in its portfolio as reported in the September 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 8.6 | $53M | 801k | 66.33 | |
| Regeneron Pharmaceuticals (REGN) | 7.7 | $48M | 311k | 152.66 | |
| Alexion Pharmaceuticals | 6.1 | $38M | 330k | 114.40 | |
| Celgene Corporation | 5.5 | $34M | 443k | 76.40 | |
| Biogen Idec (BIIB) | 4.8 | $30M | 201k | 149.23 | |
| Perrigo Company | 4.2 | $26M | 225k | 116.17 | |
| Mylan | 3.1 | $19M | 781k | 24.40 | |
| Medivation | 2.7 | $17M | 298k | 56.36 | |
| Teva Pharmaceutical Industries (TEVA) | 2.7 | $17M | 398k | 41.41 | |
| Hologic (HOLX) | 2.7 | $17M | 813k | 20.24 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.6 | $16M | 293k | 55.95 | |
| Merck & Co (MRK) | 2.2 | $13M | 297k | 45.10 | |
| Endo Pharmaceuticals | 2.0 | $13M | 393k | 31.72 | |
| Shire | 2.0 | $12M | 140k | 88.70 | |
| Akorn | 2.0 | $12M | 936k | 13.22 | |
| Neurocrine Biosciences (NBIX) | 1.6 | $10M | 1.3M | 7.98 | |
| Allergan | 1.6 | $10M | 109k | 91.58 | |
| Alere | 1.6 | $9.9M | 510k | 19.49 | |
| Vivus | 1.5 | $9.4M | 525k | 17.82 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.5 | $9.2M | 65k | 142.43 | |
| Alkermes (ALKS) | 1.4 | $8.7M | 417k | 20.75 | |
| Incyte Corporation (INCY) | 1.4 | $8.5M | 472k | 18.05 | |
| Cubist Pharmaceuticals | 1.4 | $8.5M | 179k | 47.68 | |
| ImmunoGen | 1.4 | $8.3M | 571k | 14.60 | |
| Verastem | 1.3 | $8.3M | 885k | 9.39 | |
| Thermo Fisher Scientific (TMO) | 1.3 | $8.0M | 136k | 58.83 | |
| Warner Chilcott Plc - | 1.3 | $7.9M | 586k | 13.50 | |
| Aetna | 1.3 | $7.8M | 197k | 39.60 | |
| Watson Pharmaceuticals | 1.3 | $7.8M | 92k | 85.16 | |
| Ariad Pharmaceuticals | 1.3 | $7.8M | 322k | 24.23 | |
| Impax Laboratories | 1.2 | $7.5M | 289k | 25.96 | |
| NPS Pharmaceuticals | 1.1 | $6.8M | 733k | 9.25 | |
| Covance | 1.1 | $6.5M | 140k | 46.69 | |
| Baxter International (BAX) | 1.0 | $6.3M | 105k | 60.26 | |
| Cerner Corporation | 1.0 | $6.3M | 82k | 77.41 | |
| Nektar Therapeutics (NKTR) | 1.0 | $6.3M | 586k | 10.68 | |
| IDEXX Laboratories (IDXX) | 0.9 | $5.6M | 56k | 99.35 | |
| Illumina (ILMN) | 0.9 | $5.6M | 115k | 48.20 | |
| Intellipharmaceuticsintl Inc C | 0.8 | $5.2M | 1.7M | 3.00 | |
| Jazz Pharmaceuticals (JAZZ) | 0.8 | $5.2M | 91k | 57.01 | |
| McKesson Corporation (MCK) | 0.8 | $4.9M | 57k | 86.03 | |
| Accuray Incorporated (ARAY) | 0.8 | $4.8M | 672k | 7.08 | |
| UnitedHealth (UNH) | 0.7 | $4.6M | 82k | 55.41 | |
| Amarin Corporation (AMRN) | 0.7 | $4.3M | 338k | 12.60 | |
| United Therapeutics Corporation (UTHR) | 0.7 | $4.1M | 73k | 55.88 | |
| Curis | 0.7 | $4.1M | 989k | 4.14 | |
| Bruker Corporation (BRKR) | 0.6 | $3.7M | 285k | 13.09 | |
| Acorda Therapeutics | 0.6 | $3.7M | 145k | 25.61 | |
| CVS Caremark Corporation (CVS) | 0.6 | $3.5M | 72k | 48.41 | |
| Questcor Pharmaceuticals | 0.5 | $2.9M | 158k | 18.50 | |
| Keryx Biopharmaceuticals | 0.5 | $2.8M | 983k | 2.82 | |
| Dendreon Corporation | 0.4 | $2.7M | 550k | 4.83 | |
| Ironwood Pharmaceuticals (IRWD) | 0.4 | $2.7M | 208k | 12.78 | |
| Ceres | 0.4 | $2.4M | 428k | 5.68 | |
| Zogenix | 0.3 | $1.7M | 625k | 2.66 | |
| OncoGenex Pharmaceuticals | 0.3 | $1.6M | 113k | 14.17 | |
| Aegerion Pharmaceuticals | 0.2 | $1.5M | 101k | 14.82 | |
| Threshold Pharmaceuticals | 0.2 | $1.4M | 197k | 7.24 | |
| ArQule | 0.2 | $1.3M | 250k | 5.11 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $961k | 380k | 2.53 | |
| Amgen (AMGN) | 0.1 | $844k | 10k | 84.32 | |
| Celldex Therapeutics | 0.1 | $882k | 140k | 6.30 | |
| Amicus Therapeutics (FOLD) | 0.1 | $429k | 83k | 5.20 | |
| Cornerstone Therapeutics | 0.1 | $339k | 66k | 5.13 | |
| BioMimetic Therapeutics | 0.0 | $211k | 51k | 4.11 | |
| Addus Homecare Corp (ADUS) | 0.0 | $177k | 33k | 5.40 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $174k | 104k | 1.68 | |
| Icad (ICAD) | 0.0 | $163k | 76k | 2.16 |
